CHF Solutions to Participate at Lake Street Capital Markets’ 4th Annual BIG4 Conference on September 17, 2020

Rhea-AI Summary

CHF Solutions (Nasdaq: CHFS) will participate in the Lake Street Capital Markets’ 4th Annual Best Ideas Growth Conference on September 17, 2020. Nestor Jaramillo, President, and Claudia Drayton, CFO, will engage in one-on-one meetings with investors. The company focuses on innovative medical devices to treat fluid overload, featuring the Aquadex SmartFlow™ system for ultrafiltration therapy. This system is indicated for both adult and pediatric patients and requires health care provider administration. CHF Solutions has been listed on Nasdaq since February 2012 and has subsidiaries in Australia and Ireland.

EDEN PRAIRIE, Minn., Sept. 11, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will participate in Lake Street Capital Markets’ 4^th Annual Best Ideas Growth Conference, being held virtually.  Nestor Jaramillo, President and Chief Operating Officer, and Claudia Drayton, Chief Financial Officer, will be holding one-on-one meetings with investors on Thursday, September 17, 2020.

About CHF Solutions

CHF Solutions, Inc. (CHFS) is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy. CHF Solutions is headquartered in Minneapolis, Minn., with wholly-owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

About the Aquadex SmartFlow System

The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.

About the BIG4 Conference

Lake Street Capital Markets will host its 4^th annual Best Ideas Growth (BIG4) Conference on a virtual platform, showcasing many interesting and dynamic public growth companies. Executives from approximately 90 publicly traded companies will meet institutional investors in an interactive, one-on-one format. This is an invitation-only event attended by top institutional investors from across the country.

Forward-Looking Statements

Certain statements in this release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements about its participation in this conference. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our expectations regarding the potential impacts of the COVID-19 pandemic on our business operations, our ability to execute on our commercial strategy, the possibility that we may be unable to raise sufficient funds necessary for our anticipated operations, our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. CHF Solutions does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACTS

INVESTORS:

Claudia Napal Drayton 
Chief Financial Officer, CHF Solutions, Inc. 
952-345-4205


MEDIA:

Jessica Stebing
Health+Commerce
260-336-6202

FAQ

When will CHF Solutions participate in the Lake Street Capital Markets’ conference?

CHF Solutions will participate in the Lake Street Capital Markets’ 4th Annual Best Ideas Growth Conference on September 17, 2020.

Who will represent CHF Solutions at the conference?

Nestor Jaramillo, President and COO, and Claudia Drayton, CFO, will represent CHF Solutions.

What is the Aquadex SmartFlow system used for?

The Aquadex SmartFlow system is used for ultrafiltration therapy to treat patients suffering from fluid overload.

What is the significance of the Best Ideas Growth Conference for CHF Solutions?

The conference allows CHF Solutions to engage with top institutional investors in a one-on-one format.

Is the Aquadex SmartFlow system indicated for pediatric patients?

Yes, the Aquadex SmartFlow system is indicated for both adult and pediatric patients weighing 20 kg or more.